SectorBiological Technology
Established Date07/08/2006
Listing Date19/11/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees131
Fiscal Year Ends31/12
Security TypeCommon stock
Office address780 Brannan Street, San Francisco, California 94103
Business
IntroductionOlema Pharmaceuticals, Inc., was incorporated in Delaware on August 7, 2006. The company is a clinical-stage biopharmaceutical company focused on developing next-generation targeted therapies for breast cancer. Its lead drug candidate, palazestrant, is an oral small molecule with dual activity of an estrogen receptor antagonist and a degradant, and is currently in Phase 3 trials for ER +/HER2- metastatic breast cancer.
